A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria

Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. New substances are constantly being added to the content of SCs. The dearth of information on these newly added conten...

Full description

Saved in:
Bibliographic Details
Main Authors: Osamah Hasan, Ankit A. Patel, James J. Siegert
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2019/6327819
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546143391711232
author Osamah Hasan
Ankit A. Patel
James J. Siegert
author_facet Osamah Hasan
Ankit A. Patel
James J. Siegert
author_sort Osamah Hasan
collection DOAJ
description Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. New substances are constantly being added to the content of SCs. The dearth of information on these newly added contents as they are introduced into the black market hinders risk assessments of these compounds. We report a highly unusual case of gross hematuria in a 28-year-old male patient after SC use. He was found to have a supratherapeutic INR with no history of prior anticoagulation. His hematuria resolved after four units of fresh-frozen plasma were administered. We include a literature review of the clinical effects of SCs and their possible mechanism of gross hematuria and management.
format Article
id doaj-art-84352f042a054bc28220355a029b6001
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-84352f042a054bc28220355a029b60012025-02-03T07:23:49ZengWileyCase Reports in Medicine1687-96271687-96352019-01-01201910.1155/2019/63278196327819A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross HematuriaOsamah Hasan0Ankit A. Patel1James J. Siegert2Midwestern University, 555 31st St., Downers Grove, IL 60515, USAMidwestern University, 555 31st St., Downers Grove, IL 60515, USAMidwestern University, 555 31st St., Downers Grove, IL 60515, USARecreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. New substances are constantly being added to the content of SCs. The dearth of information on these newly added contents as they are introduced into the black market hinders risk assessments of these compounds. We report a highly unusual case of gross hematuria in a 28-year-old male patient after SC use. He was found to have a supratherapeutic INR with no history of prior anticoagulation. His hematuria resolved after four units of fresh-frozen plasma were administered. We include a literature review of the clinical effects of SCs and their possible mechanism of gross hematuria and management.http://dx.doi.org/10.1155/2019/6327819
spellingShingle Osamah Hasan
Ankit A. Patel
James J. Siegert
A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
Case Reports in Medicine
title A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
title_full A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
title_fullStr A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
title_full_unstemmed A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
title_short A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
title_sort new differential diagnosis synthetic cannabinoid associated gross hematuria
url http://dx.doi.org/10.1155/2019/6327819
work_keys_str_mv AT osamahhasan anewdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria
AT ankitapatel anewdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria
AT jamesjsiegert anewdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria
AT osamahhasan newdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria
AT ankitapatel newdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria
AT jamesjsiegert newdifferentialdiagnosissyntheticcannabinoidassociatedgrosshematuria